This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Osaka University, Toray Industries, Inc.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2013
Title: Akiko Soneda: Innovator in Immunostimulatory Oligonucleotides
Introduction
Akiko Soneda is a prominent inventor based in Kanagawa, Japan. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on immunostimulatory oligonucleotides. Her research focuses on enhancing immune responses while minimizing inflammatory reactions, which is crucial for developing effective therapies.
Latest Patents
One of Akiko Soneda's notable patents is titled "Immunostimulatory oligonucleotides and use thereof in pharmaceuticals." This patent describes a novel immunostimulatory oligonucleotide that enhances interferon-inducing activity while reducing inflammatory cytokine-inducing activity. The oligonucleotide is characterized by a specific base sequence and has applications in pharmaceutical formulations. The detailed formula includes a base sequence represented by 5'-(G)PXCGYQ(G)-3' (SEQ ID NO: 118), where X and Y represent arbitrary sequences of nucleotides, contributing to the oligonucleotide's unique properties. This invention holds promise for advancing therapeutic strategies in immunology.
Career Highlights
Throughout her career, Akiko Soneda has worked with esteemed organizations such as Toray Industries, Inc. and Osaka University. Her experience in these institutions has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Hajime Masumoto and Tomokatsu Iwamura. Their collaborative efforts have furthered the understanding and application of immunostimulatory oligonucleotides in pharmaceuticals.
Conclusion
Akiko Soneda's innovative work in the development of immunostimulatory oligonucleotides represents a significant advancement in pharmaceutical research. Her contributions are paving the way for new therapeutic approaches in immunology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile